Form 8-K - Current report:
SEC Accession No. 0001213900-24-113500
Filing Date
2024-12-30
Accepted
2024-12-30 16:30:07
Documents
20
Period of Report
2024-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0226200-8k_180life.htm   iXBRL 8-K 42624
2 PLACEMENT AGENCY AGREEMENT ea022620001ex1-1_180life.htm EX-1.1 64076
3 COMMON STOCK PURCHASE WARRANT ea022620001ex4-1_180life.htm EX-4.1 92659
4 OPINION OF THE LOEV LAW FIRM, PC ea022620001ex5-1_180life.htm EX-5.1 11601
5 SECURITIES PURCHASE AGREEMENT ea022620001ex10-1_180life.htm EX-10.1 241160
6 PRESS RELEASE DATED DECEMBER 27, 2024 ea022620001ex99-1_180life.htm EX-99.1 16479
7 GRAPHIC ex5-1_001.jpg GRAPHIC 39675
  Complete submission text file 0001213900-24-113500.txt   861774

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE atnf-20241227.xsd EX-101.SCH 3763
9 XBRL DEFINITION FILE atnf-20241227_def.xml EX-101.DEF 26613
10 XBRL LABEL FILE atnf-20241227_lab.xml EX-101.LAB 36680
11 XBRL PRESENTATION FILE atnf-20241227_pre.xml EX-101.PRE 25237
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0226200-8k_180life_htm.xml XML 5798
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 241590199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)